Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral therapy may reduce anxiety and improve the well-being and quality of life of patients who have stage IV non-small cell lung cancer and their caregivers.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- other : counseling intervention
- other : questionnaire administration
- procedure : quality-of-life assessment
Ages Eligible For Study:
- Diagnosis of stage IV non-small cell lung cancer - At least 6 weeks post-diagnosis - Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14) - Ability to understand and the willingness to sign a written informed consent document - CAREGIVER: Identified by patient as primary caregiver - CAREGIVER: At least 14 hours/week spent caring for patient - CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14) - CAREGIVER: Ability to understand and the willingness to sign a written informed consent document